Impact of Iron Injection on Blood Donation
NCT03014921 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2017-01-09
Summary
This trial study and compare in blood and urinary matrices the impact of an iron injection on proteins involved in iron metabolism during a blood donation. The goal is to study the impact of an iron injection on detection markers of a blood donation in the anti-doping field
Conditions
Interventions
- OTHER
-
iron injection
Injection of a 250mL saline solution added with 500mg of iron (Ferinject)
- OTHER
-
saline solution injection
Injection of a 250mL saline solution
Sponsors & Collaborators
-
Centre Hospitalier Universitaire Vaudois
collaborator OTHER -
Nicolas Leuenberger
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-04-30
More Related Trials
-
Iron Depletion and Replacement in Blood Donors
NCT01752413 ·Status: COMPLETED ·Phase: NA
-
Iron Replacement in Blood Donors
NCT00327067 ·Status: COMPLETED
-
Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
NCT03079518 ·Status: COMPLETED ·Phase: PHASE2
-
A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia
NCT00399191 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood Transfusion
NCT04061655 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients
NCT03662789 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intravenous High Dose Iron in Blood Donors
NCT01787526 ·Status: COMPLETED ·Phase: PHASE3
-
Plasma Hepcidin Response to Differently Dosed Iron Supplements
NCT04735848 ·Status: COMPLETED ·Phase: NA
-
Iron Long-Term Labelling Study Switzerland
NCT02979132 ·Status: UNKNOWN ·Phase: NA
-
Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
NCT05514951 ·Status: COMPLETED ·Phase: NA
-
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
NCT01925703 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
NCT03037931 ·Status: COMPLETED ·Phase: PHASE3
-
Serum Hepcidin Immunoassay - Laboratory to Marketplace
NCT03310736 ·Status: COMPLETED
-
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
NCT01374919 ·Status: COMPLETED ·Phase: NA
-
Sucrosomial Iron and Iron Sulphate to Blood Donors
NCT05678647 ·Status: COMPLETED ·Phase: NA
-
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
NCT05153278 ·Status: COMPLETED
-
Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal Women
NCT01374776 ·Status: COMPLETED ·Phase: PHASE4
-
Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency
NCT04139265 ·Status: COMPLETED
-
Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women
NCT04636060 ·Status: COMPLETED ·Phase: NA
-
Intravenous Iron Effects on Performance at High Altitude
NCT06686693 ·Status: RECRUITING ·Phase: PHASE4
-
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
NCT01984554 ·Status: COMPLETED
-
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
NCT03188445 ·Status: COMPLETED ·Phase: PHASE4
-
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
NCT01309659 ·Status: TERMINATED ·Phase: PHASE2
-
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
NCT03036462 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
NCT01394562 ·Status: COMPLETED ·Phase: PHASE3